Medical Terminology


« Back to Glossary Index

Solriamfetol (Sunosi) is a non-stimulant wake-promoting medication that was approved in March 2019 by the U.S. FDA for the treatment of sleepiness caused by narcolepsy and obstructive sleep apnea. It is the first dual-acting dopamine and norepinephrine reuptake inhibitor (NDRI) approved to treat excessive daytime sleepiness in adults. Read more about solriamfetol at HERE and on HF’s Treatment web page HERE.